Total Clarity Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Total Clarity Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-524	Closed	-$29K	–	473
2022 Q2	$29K	Buy	+524	New	+$28.8K	0.02%	495
2022 Q1	–	Sell	-889	Closed	-$89K	–	442
2021 Q4	$89K	Buy	889 +9	+1%	+$791	0.04%	331
2021 Q3	$79K	Buy	+880	New	+$80K	0.04%	338
2021 Q2	–	Sell	-880	Closed	-$85K	–	367
2021 Q1	$85K	Buy	+880	New	+$90.8K	0.05%	262
2020 Q1	–	Sell	-400	Closed	-$5K	–	254
2019 Q4	$5K	Buy	+400	New	+$4.75K	﹤0.01%	580

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Total Clarity Wealth Management's FLGT Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 524 shares — an estimated $29K sold.

Total Clarity Wealth Management first reported a position in FLGT in Q4 2019 and held it in 5 quarters. The position peaked at $89K in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

Total Clarity Wealth Management reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 524 Fulgent Genetics shares in Q3 2022, an estimated $29K.
Total Clarity Wealth Management first reported a position in Fulgent Genetics in Q4 2019 and held it in 5 quarters.
Total Clarity Wealth Management's Fulgent Genetics position peaked at $89K in Q4 2021.
235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.